The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer

Details 詳細情報について

• CRID

  1360013173181593984

• DOI

  10.21037/tlcr-20-379

• ISSN

  22264477

  22186751

• Web Site

  http://tlcr.amegroups.com/article/download/44003/pdf

• Data Source

  • Crossref